ProShare Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Sell |
15,282
-1,947
| -11% | -$18.3K | ﹤0.01% | 1799 |
|
|
2025
Q1 | $93.4K | Sell |
17,229
-4,450
| -21% | -$24.1K | ﹤0.01% | 1846 |
|
|
2024
Q4 | $162K | Buy |
21,679
+8,981
| +71% | +$66.9K | ﹤0.01% | 1951 |
|
|
2024
Q3 | $101K | Buy |
+12,698
| New | +$101K | ﹤0.01% | 1879 |
|
|
2024
Q2 | – | Sell |
-10,121
| Closed | -$209K | – | 1899 |
|
|
2024
Q1 | $209K | Buy |
+10,121
| New | +$209K | ﹤0.01% | 1650 |
|
|
2020
Q4 | – | Sell |
-2,018
| Closed | -$10K | – | 2094 |
|
|
2020
Q3 | $10K | Buy |
2,018
+25
| +1% | +$124 | ﹤0.01% | 1638 |
|
|
2020
Q2 | $15K | Buy |
1,993
+135
| +7% | +$1.02K | ﹤0.01% | 1665 |
|
|
2020
Q1 | $19K | Sell |
1,858
-1,335
| -42% | -$13.7K | ﹤0.01% | 1137 |
|
|
2019
Q4 | $49K | Sell |
3,193
-390
| -11% | -$5.99K | ﹤0.01% | 1750 |
|
|
2019
Q3 | $65K | Buy |
3,583
+487
| +16% | +$8.84K | ﹤0.01% | 1582 |
|
|
2019
Q2 | $51K | Sell |
3,096
-130
| -4% | -$2.14K | ﹤0.01% | 1570 |
|
|
2019
Q1 | $58K | Buy |
3,226
+11
| +0.3% | +$198 | ﹤0.01% | 1607 |
|
|
2018
Q4 | $61K | Buy |
+3,215
| New | +$61K | ﹤0.01% | 1518 |
|